International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Committee.

About this item

Title

International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Committee.

Content partner

The University of Auckland Library

Collection

ResearchSpace@Auckland

Description

The Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention (TRS2°P), a 0-to-9-point system based on the presence/absence of 9 clinical factors, was developed to classify the risk of major adverse cardiovascular events (MACE) (a composite of cardiovascular death, recurrent myocardial infarction, or ischemic stroke) among patients with a recent myocardial infarction. Its performance has not been examined internationally outside of a clinical trial setting. We evaluated...

Read more

Format

Research paper

Research format

Journal article

Date created

2018-07-07

Creator

Mok, Yejin / Ballew, Shoshana H / Bash, Lori D / Bhatt, Deepak L / Boden, William E / Bonaca, Marc P / Carrero, Juan Jesus / Coresh, Josef / D'Agostino, Ralph B / Elley, C Raina / Fowkes, F Gerry R / Jee, Sun Ha / Kovesdy, Csaba P / Mahaffey, Kenneth W / Nadkarni, Girish / Peterson, Eric D / Sang, Yingying / Matsushita, Kunihiro

URL

https://hdl.handle.net/2292/60968

Related subjects

Humans / Brain Ischemia / Cardiovascular Diseases / Myocardial Infarction / Hypertension / Diabetes Mellitus / Recurrence / Proportional Hazards Models / Risk Assessment / Cohort Studies / Reproducibility of Results / Smoking / Age Factors / Aged / Middle Aged / United States / Sweden / New Zealand / Female / Male / Renal Insufficiency / Heart Failure / Stroke / Secondary Prevention / Republic of Korea / Peripheral Arterial Disease / validation / Heart Disease / Cardiovascular / Prevention / Patient Safety / Clinical Research / Atherosclerosis / Heart Disease - Coronary Heart Disease / 1102 Cardiorespiratory Medicine and Haematology / Clinical / Clinical Medicine and Science

What is the copyright status of this item?

Share, Modify

See below for specifics about how you may use this item.

More Information

The University of Auckland Library has this to say about the rights status of this item:

Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.

You can learn more about the rights status of this item at:

• https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm
• https://creativecommons.org/licenses/by-nc/4.0/
• http://purl.org/eprint/accessRights/OpenAccess

What can I do with this item?

You must always check with The University of Auckland Library to confirm the specific terms of use, but this is our understanding:

Non-infringing use

NZ Copyright law does not prevent every use of a copyright work. You should consider what you can and cannot do with a copyright work.

Share it

This item is suitable for copying and sharing with others, without further permission.

Modify it

This item is suitable for modifying, remixing and building upon, without further permission.

No commercial use

You may not use this item commercially.